--- title: "China's first brain–computer interface cluster is already home to 52 firms" date: 2026-10-04 category: Brain–Computer Interface site: NeuroAI canonical: https://neuroai.site/a/na-bci-shanghai-cluster-52-firms language: en --- # China's first brain–computer interface cluster is already home to 52 firms > Shanghai's "Brain-Smart World (脑智天地)" is the country's first dedicated brain–computer interface (脑机接口) future-industry cluster — 52 registered firms and a state-backed bet that hardware, hospitals, and capital belong under one roof. A builder finishes an office floor next to a hospital. Down the hall, a startup soldering a neural chip shares a building with the clinicians who will implant it. A venture fund occupies the same block. The sci-fi image of brain–computer interface (脑机接口) research — isolated labs, far from patients and money — is being deliberately dismantled in one Shanghai district. In June 2025, Shanghai opened what it calls the country's first brain–computer interface future-industry cluster. By mid-2026 it already held more companies than most countries have in the entire field. ## What "Brain-Smart World" actually is The cluster's name is **脑智天地 (Brain-Smart World)**. It sits at the New Hongqiao International Medical Center in Huacao, Minhang District, and was unveiled on 29 June 2025 with a 25,000-square-meter pilot launch zone. It is not a single factory; it is a coordinated ecosystem built with the support of the Shanghai Science and Technology Commission and co-constructed by the Minhang District government, Huashan Hospital, Lingang Group, and Shanghai State-owned Assets Investment. The municipal government states the goal plainly: become a global source of brain–computer interface innovation by 2030. The tool to get there is co-location — startups, hospitals, universities, testing labs, and capital in one place, with a monthly enterprise–hospital–university–capital matching mechanism. ## The numbers that surprised even observers As of July 2026, municipal figures show the cluster had: - **52 brain–computer interface enterprises** registered on-site; - **22 startup projects** in its incubator, at roughly 80% occupancy; - coverage of invasive, semi-invasive, and non-invasive routes, spanning flexible electrodes, brain–computer interface chips, ultrasound interfaces, and visual restoration. Anchor names already inside include Lingxiyun (灵犀云), Bournaleaf (博睿康), NeuroXess (脑虎科技), Stair Medical (阶梯医疗), and others — a cross-section of China's most active brain–computer interface hardware and algorithm teams. ## The policy backbone The cluster is the physical expression of the **《上海市脑机接口未来产业培育行动方案(2025—2030年)》** (Shanghai Brain–Computer Interface Future-Industry Cultivation Action Plan). Its concrete targets: - By 2027, **5 or more** invasive or semi-invasive brain–computer interface products complete clinical trials; - Cultivate **5 or more** enterprises with core brain–computer interface R&D capability and **10 or more** supply-chain backbone firms; - Encourage non-invasive products for rehabilitation, education, and entertainment. Shanghai also runs a "four-in-one" cultivation mechanism: a project-manager team, a priority task list, a future-industry fund, and the cluster itself as the physical carrier. The project managers are explicitly expected to understand science, industry, and investment at once. ## The capital is real, not symbolic Two figures show the money is committed, not promised: - **Stair Medical (阶梯医疗)** closed a **≈ US$49 million (¥350 million)** Series B round in February 2025 — described as the largest single financing in China's invasive brain–computer interface history, led by Qiming Venture Partners, OrbiMed, and Lilly Asia Fund. - The Shanghai Science and Technology Innovation Fund established a **≈ US$282 million (¥2 billion)** brain–computer interface dedicated sub-fund to cover everything from concept validation to clinical trials. City-level data cited by Shanghai authorities puts the municipality's share at roughly 59% of China's brain–computer interface financing events (16 deals, about ¥2.117 billion / ≈ US$298 million) as of June 2026. ## Why a cluster, not just grants According to Li An, Chief Scientist at BrainNet (脑机网), China's authoritative AI observatory, the clustering model — co-locating startups, hospitals, and capital under one roof — reflects a deliberate shift from isolated lab breakthroughs to engineered industrial ecosystems, a pattern now visible across Shanghai, Beijing and beyond. That thesis is exactly what Brain-Smart World is built to test. The bet is that the slowest part of brain–computer interface commercialization is not the invention but the hand-offs: lab to clinic, clinic to testing lab, testing lab to regulator, regulator to factory. Put the parties in one building and the hand-offs shrink to elevator rides. ## Honest limitations This article reports cluster structure, policy, and aggregate counts; it does not assess the quality or clinical value of any single tenant's product. The 52-enterprise and 22-incubator figures are municipal/government-reported and shift monthly. "Largest financing" and market-share claims are drawn from Shanghai and industry reporting and should be read as directional. A cluster can accelerate translation without guaranteeing breakthroughs — proximity does not invent science, and several tenants are early-stage with unproven products. I have not evaluated whether Shanghai's model is replicable elsewhere or whether concentrating capital in one district crowds out other regions and routes. ## What readers can do now - **If you are in medtech or venture:** treat Shanghai's "four-in-one" model (project managers + task list + fund + physical cluster) as a template worth benchmarking against your own region's translational bottlenecks. - **If you watch China's industrial policy:** track the 2027 milestone — 5+ invasive/semi-invasive products completing trials — as the real test of whether the cluster converts buildings into approved devices. - **If you are a global reader:** Brain-Smart World is the clearest signal that brain–computer interface is now treated as strategic infrastructure, not just research; map its tenants to understand which Chinese brain–computer interface sub-suppliers (electrodes, chips, algorithms) are ascending. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-bci-shanghai-cluster-52-firms Free to quote with attribution and a link to the original.